Cargando…
Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder Cancer
Cancer cells utilize vitamin folate to fulfill their excessive demand for nucleotides and amino acids. Dihydrofolate reductase (DHFR), an enzyme involved in folate metabolism converts dihydrofolate into tetrahydrofolate, which is required for the de novo synthesis of purines, and certain amino acids...
Autores principales: | Eich, Marie-Lisa, Rodriguez Pena, Maria Del Carmen, Chandrashekar, Darshan Shimoga, Chaux, Alcides, Agarwal, Sumit, Gordetsky, Jennifer B., Ferguson, James E., Sonpavde, Guru P., Netto, George J., Varambally, Sooryanarayana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700437/ https://www.ncbi.nlm.nih.gov/pubmed/31401334 http://dx.doi.org/10.1016/j.tranon.2019.07.012 |
Ejemplares similares
-
A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression()
por: Chakravarthi, Balabhadrapatruni V.S.K., et al.
Publicado: (2018) -
The catalytic mechanism of the mitochondrial methylenetetrahydrofolate dehydrogenase/cyclohydrolase (MTHFD2)
por: Zhao, Li Na, et al.
Publicado: (2022) -
MTHFD1L, A Folate Cycle Enzyme, Is Involved in Progression of Colorectal Cancer()()
por: Agarwal, Sumit, et al.
Publicado: (2019) -
Xanthine Derivatives
Reveal an Allosteric Binding
Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2)
por: Lee, Lung-Chun, et al.
Publicado: (2021) -
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors
por: Rehman, Hasibur, et al.
Publicado: (2022)